IQ2 debate: Is "Big Pharma" to blame for rising health care costs?

Independent pharmacist John Hoeschen is concerned that if Target and Wal-Mart are allowed to sell prescription drugs at lower prices, his business will be hurt.
MPR Photo/Tom Scheck

An Intelligence Squared debate on the motion: 'Is "Big Pharma" to blame for rising health care costs?'

FOR the motion: Ezekiel Emanuel, chair of the Department of Medical Ethics and Policy at the University of Pennsylvania, and a White House special adviser on health policy who helped shape the Affordable Care Act.

Neera Tanden, president and CEO of The Center for American Progress who served as an adviser on health care reform in the Obama administration.

AGAINST the motion: Paul Howard, director of health policy and senior fellow at the Manhattan Institute and also a member of Project FDA, which aims to reform the FDA.

Lori Reilly, executive vice president for Policy, Research and Membership at the Pharmaceutical Research and Manufacturers of American. (PhRMA)

To listen to the full debate, click the play button above.

Your support matters.

You make MPR News possible. Individual donations are behind the clarity in coverage from our reporters across the state, stories that connect us, and conversations that provide perspectives. Help ensure MPR remains a resource that brings Minnesotans together.